[{"address1": "11400 West Olympic Boulevard", "address2": "Suite 200", "city": "Los Angeles", "state": "CA", "zip": "90064", "country": "United States", "phone": "310 651 8041", "website": "https://www.immixbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 for relapsed/refractory multiple myeloma. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ilya  Rachman M.B.A., M.D., MBA, Ph.D.", "age": 51, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 669000, "exercisedValue": 0, "unexercisedValue": 1846232}, {"maxAge": 1, "name": "Mr. Gabriel  Morris B.A.", "age": 37, "title": "CFO & Director", "yearBorn": 1987, "fiscalYear": 2023, "totalPay": 669000, "exercisedValue": 0, "unexercisedValue": 3188312}, {"maxAge": 1, "name": "Dr. Graham  Ross FFPM, M.D.", "age": 64, "title": "Chief Medical Officer & Head of Clinical Development", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 104423, "exercisedValue": 0, "unexercisedValue": 55346}, {"maxAge": 1, "name": "Mr. Sean  Senn J.D., M.B.A., M.Sc., MBA, MSc", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.", "age": 77, "title": "Scientific Co-Founder", "yearBorn": 1947, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nandan  Oza B.S.", "age": 62, "title": "Head of Chemistry, Manufacturing & Control", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerhard  Bauer", "title": "Head of Cell Therapy Manufacturing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.99, "open": 2.0, "dayLow": 1.85, "dayHigh": 2.0, "regularMarketPreviousClose": 1.99, "regularMarketOpen": 2.0, "regularMarketDayLow": 1.85, "regularMarketDayHigh": 2.0, "beta": 0.228, "forwardPE": -2.7123287, "volume": 64846, "regularMarketVolume": 64846, "averageVolume": 170125, "averageVolume10days": 85840, "averageDailyVolume10Day": 85840, "bid": 1.44, "ask": 2.43, "bidSize": 200, "askSize": 200, "marketCap": 54465048, "fiftyTwoWeekLow": 1.26, "fiftyTwoWeekHigh": 3.799, "fiftyDayAverage": 2.12866, "twoHundredDayAverage": 1.991495, "currency": "USD", "enterpriseValue": 35863744, "floatShares": 17772134, "sharesOutstanding": 27507600, "sharesShort": 335267, "sharesShortPriorMonth": 356527, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.012200001, "heldPercentInsiders": 0.40098, "heldPercentInstitutions": 0.12255, "shortRatio": 3.26, "shortPercentOfFloat": 0.0388, "impliedSharesOutstanding": 27646600, "bookValue": 0.639, "priceToBook": 3.0985916, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -21890826, "trailingEps": -0.84, "forwardEps": -0.55, "enterpriseToEbitda": -1.556, "52WeekChange": -0.33444816, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "IMMX", "underlyingSymbol": "IMMX", "shortName": "Immix Biopharma, Inc.", "longName": "Immix Biopharma, Inc.", "firstTradeDateEpochUtc": 1639665000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "a16f90b7-2d1a-3bc1-ad13-b52d1a275ae3", "messageBoardId": "finmb_417356223", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.98, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 19690432, "totalCashPerShare": 0.716, "ebitda": -23047998, "totalDebt": 1089055, "quickRatio": 3.3, "currentRatio": 3.466, "debtToEquity": 6.205, "returnOnAssets": -0.60545, "returnOnEquity": -1.18504, "freeCashflow": -8295194, "operatingCashflow": -15796341, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]